Marie Curie Palliative Care Research Department, University College London, London, UK.
Department of Primary Care and Population Health, Centre for Ageing Population Studies, Royal Free Campus, University College London, London, UK.
Health Expect. 2022 Aug;25(4):1954-1966. doi: 10.1111/hex.13552. Epub 2022 Jun 18.
COVID-19 has disproportionately affected people living with dementia and their carers. Its effects on health and social care systems necessitated a rapid-response approach to care planning and decision-making in this population, with reflexivity and responsiveness to changing individual and system needs at its core. Considering this, a decision-aid to help families of persons with dementia was developed.
To coproduce with people living with dementia, and the people who care for them, a decision-aid for family carers of people living with dementia, to support decisions during the COVID-19 pandemic and beyond.
Semi-structured interviews were undertaken in 2020 with: (1) staff from two English national end-of-life and supportive care organizations; and (2) people living with dementia and family carers. Simultaneously, a rapid review of current evidence on making decisions with older people at the end of life was undertaken. Evidence from these inputs was combined to shape the decision-aid through a series of workshops with key stakeholders, including our patient and public involvement group, which consisted of a person living with dementia and family carers; a group of clinical and academic experts and a group of policy and charity leads.
The rapid review of existing evidence highlighted the need to consider both process and outcome elements of decision-making and their effects on people living with dementia and their families. The qualitative interviews discussed a wide range of topics, including trust, agency and confusion in making decisions in the context of COVID-19. The decision-aid primarily focussed on care moves, legal matters, carer wellbeing and help-seeking.
Combining different sources and forms of evidence was a robust and systematic process that proved efficient and valuable in creating a novel decision-aid for family carers within the context of COVID-19. The output from this process is an evidence-based practical decision-aid coproduced with people living with dementia, family carers, clinical and academic experts and leading national dementia and palliative care organizations.
We worked with people living with dementia and family carers and other key stakeholders throughout this study, from study development and design to inclusion in stakeholder workshops and dissemination.
COVID-19 对患有痴呆症的人和他们的照顾者造成了不成比例的影响。为了应对这一情况,需要对这一人群的护理计划和决策进行快速反应,核心是反思和响应个人和系统需求的变化。考虑到这一点,开发了一种帮助痴呆症患者家庭的决策辅助工具。
与患有痴呆症的人和照顾他们的人共同制作一种痴呆症患者家庭照顾者的决策辅助工具,以支持在 COVID-19 大流行期间及以后的决策。
2020 年,我们对以下人员进行了半结构化访谈:(1)两家英国临终关怀和支持护理组织的工作人员;(2)患有痴呆症的人和家庭照顾者。同时,我们对老年人在生命末期做出决策的现有证据进行了快速审查。从这些投入中获取的证据通过一系列与主要利益相关者的研讨会进行了结合,包括我们的患者和公众参与小组,该小组由一名患有痴呆症的人和家庭照顾者、一组临床和学术专家以及一组政策和慈善机构领导组成。
对现有证据的快速审查强调了需要考虑决策的过程和结果要素,以及它们对患有痴呆症的人和他们的家庭的影响。定性访谈讨论了广泛的主题,包括在 COVID-19 背景下决策中的信任、代理和困惑。决策辅助工具主要集中在护理转移、法律问题、照顾者的幸福感和寻求帮助上。
结合不同来源和形式的证据是一个稳健而系统的过程,在 COVID-19 背景下为家庭照顾者创建新的决策辅助工具证明是高效和有价值的。该过程的结果是一种基于证据的实用决策辅助工具,是与患有痴呆症的人、家庭照顾者、临床和学术专家以及领先的国家痴呆症和姑息治疗组织共同制作的。
在整个研究过程中,我们与患有痴呆症的人和家庭照顾者以及其他关键利益相关者合作,从研究的开发和设计到利益相关者研讨会的参与和传播。